Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

The $200 Popcorn Popper That Keeps Selling Out

October 1, 2026

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » The Worldwide Clinical Trial Patient Recruitment Services Market Set for Expansion with a Projected CAGR of 9.63% by 2030
Press Release

The Worldwide Clinical Trial Patient Recruitment Services Market Set for Expansion with a Projected CAGR of 9.63% by 2030

By News RoomJanuary 22, 20244 Mins Read
The Worldwide Clinical Trial Patient Recruitment Services Market Set for Expansion with a Projected CAGR of 9.63% by 2030
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) — The “Global Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group – Forecast 2024-2030” report has been added to ResearchAndMarkets.com’s offering.

The latest research publication on the Clinical Trial Patient Recruitment Services Market has been released, offering an in-depth analysis with forecasts up to 2030, imperative for industry stakeholders and investors.

Segmented by therapeutic areas such as Anti-Infective, Cardiovascular, Central Nervous System, and several other categories, the study provides an extensive market outlook, dissecting crucial aspects ranging from technology trends to regulatory frameworks.

Market Insights and Development Strategies

The report offers a rich tapestry of market intelligence, covering key points such as market penetration and competitive intelligence. Insights gathered through the FPNV Positioning Matrix and Market Share Analysis provide a basis for strategic planning, highlighting diverse opportunities for market development.

With an estimated market size of USD 1.16 billion in 2023 and expected growth to reach USD 2.22 billion by 2030, the comprehensive evaluation of market dynamics explores innovative profiles of key leaders and their contributions to the industry’s evolution.

Comprehensive Therapeutic Area Assessment

The scalable nature of different therapeutic areas is underscored, capturing the sector’s robust demand across a spectrum encompassing Anti-Infective to Central Nervous System. The report also spans age group analysis and different phases of clinical trials, including Phase I, Phase II, Phase III, and Phase IV, offering stakeholders detailed strategic intelligence.

Geographical Market Diversity

Vital revenue forecasts for prominent geographic regions, including Americas, Asia-Pacific, and Europe, Middle East & Africa, are unfolded, spotlighting regions such as the United States and emerging markets like India and China. Detailed coverage of these areas fuels informed decision-making for global market participants.

Vendor Landscape & Evolving Trends

  • Key Company Profiles: An exhaustive roster of market participants is examined, showcasing the strategic imperatives of industry frontrunners.
  • Market Segmentation: A thorough analysis of segments provides clarity on market trends and revenue generation potentials.

The publication articulates strategic insights and granular analysis, pivotal for tapping into high-growth niches and comprehending the competitive landscape of the Clinical Trial Patient Recruitment Services Market. The inquiry into the market’s future trajectory is now accessible, elucidating growth prospects and market dynamics with precision.

Anticipating the directions of technological advancements and monitoring the pulse of market shifts, the report is an indispensable tool for businesses aiming to harness the full potential of the Clinical Trial Patient Recruitment Services Market.

The report stands as a guiding light for entities aiming at fortifying their market presence and seeking detailed intelligence on investment opportunities, innovative advancements, and the competitive canvas of the Clinical Trial Patient Recruitment Services Market.
Key Attributes:

Report Attribute Details
No. of Pages 198
Forecast Period 2024 – 2030
Estimated Market Value (USD) in 2024 $1.27 Billion
Forecasted Market Value (USD) by 2030 $2.22 Billion
Compound Annual Growth Rate 9.6%
Regions Covered Global

Market Overview

Drivers

  • Increasing number of clinical trials all over the globe
  • Rapid adoption of patient recruitment sevices by clinical trial organizations
  • Government support for patient engagement programs

Restraints

  • Concern associated with substantial cost of the PR services

Opportunities

  • Ongoing research and development activities in pharmaceuticals and biotechnology sector
  • Collaborative efforts to enhance the growth of the clinical trials patient recruitment services

Challenges

  • Lack of awareness about clinical trials in patients
  • Market Segmentation Analysis

Companies Mentioned

  • Antidote Technologies, Inc.
  • AutoCruitment LLC by QHP Capital
  • BBK Worldwide, LLC
  • Biorasi, LLC
  • Clara Health by M&B Sciences Inc.
  • Clariness GmbH
  • Clinical Site Services (CCSi)
  • Conduent, Inc.
  • Elligo Health Research
  • IQVIA Inc. by Q2 Metrics
  • Matthews Media Group Inc.
  • MESM Ltd by VWR
  • PatientEvolution
  • PPD Inc. by Thermo Fisher Scientific
  • Science 37, Inc. by LifeSci Acquisition II Corp.
  • Syneos Health
  • Trialbee AB
  • Trialfacts
  • Veristat
  • Worldwide Clinical Trials

For more information about this report visit https://www.researchandmarkets.com/r/jj1lo9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Clinical Trial Patient Recruitment Services Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

The $200 Popcorn Popper That Keeps Selling Out

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya

The News Forum Presents Aftershock: The World After October 7, 2023

BloFin returns as TOKEN2049 Singapore title sponsor, opens its “NEXT WHALE ERA” chapter with 3rd anniversary afterparty

Editors Picks

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026

Latest News

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

October 1, 2026

Police seek answers in crash that killed 2 elders, hurt 2 others on BC First Nation

October 1, 2026

An AI agent tried to hack Canadian government website, researchers say

October 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version